SCHEMBL4253487

SCHEMBL4253487

CNC(=O)COc1ccc2c(c1)CC2CN(CCC(=O)N1CCc2cc(OC)c(OC)cc2CC1)C(=O)OC(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.41
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.38
ALDH1A1 P00352 1/20 0.38
CHRM2 P08172 1/20 0.36
HTR1A P08908 1/20 0.36
SLC6A4 P31645 1/20 0.36
DRD3 P35462 1/20 0.36
KCNH2 Q12809 1/20 0.36
HCN4 Q9Y3Q4 1/20 0.36
GHSR Q92847 4/20 0.35
GPER1 Q99527 1/20 0.35
ABCB1 P08183 1/20 0.34
ABCC1 P33527 1/20 0.34
HPGD P15428 1/20 0.34
HTT P42858 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4247360 0.88 CHRM2 (0.45) MAPTKMT2AMEN1SMN1; SMN2ALDH1A1
SCHEMBL4247516 0.87 ABCB1 (0.40) MAPTKMT2AMEN1CHRM2HTR1A
SCHEMBL4247539 0.85 ESR2 (0.42) MAPTKMT2ASMN1; SMN2ALDH1A1CHRM2
SCHEMBL4250522 0.84 KMT2A (0.41) MAPTKMT2AMEN1SMN1; SMN2ALDH1A1
SCHEMBL4248373 0.82 KMT2A (0.36) MAPTKMT2AMEN1SMN1; SMN2ALDH1A1
Hydrochloric Acid SCHEMBL4243341 0.80 MAPT (0.44) MAPTKMT2AMEN1SMN1; SMN2ALDH1A1
SCHEMBL4247356 0.80 ESR2 (0.42) MAPTKMT2ASMN1; SMN2ALDH1A1CHRM2
SCHEMBL4253490 0.80 MAPT (0.41) MAPTKMT2AMEN1SMN1; SMN2ALDH1A1
SCHEMBL3155094 0.77 CHRM2 (0.47) MAPTKMT2AMEN1SMN1; SMN2ALDH1A1
Hydrochloric Acid SCHEMBL4249161 0.76 CHRM2 (0.46) MAPTKMT2AMEN1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8076325-B2 1,2,4,5-tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER (FR) 2011-12-13 US disclosed
US-20090069296-A1 1,2,4,5-Tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER (FR) 2009-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069296-A1 1,2,4,5-Tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them OXER1, NR1H3, OXSR1 MAPT 2717/4885KMT2A 1570/4885MEN1 2079/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.